Cancer-derived CD8+ T cells from patients with head and neck cancer when co-cultured with tumor-derived EVs has been shown to induce the loss of CD27 expression in CD8+ T-cell and thus resulting in their change from the anti-tumor phenotype towards a more potent tumor suppressor phenotype [154,155,156]. This evidence concerns the gene CD8A and head and neck cancer.